DC10042 |
THZ1 Hydrochloride
|
THZ1 Hydrochloride 是有效,选择性的共价 CDK7 抑制剂,IC50 为 3.2 nM。THZ1 Hydrochloride 还抑制相关的激酶 CDK12 和 CDK13,并下调 MYC 表达。 |
DC9394 |
LDC000067
|
LDC000067(LDC-067) is a highly specific CDK9 inhibitor with IC50 of 32.7 nM for CDK9/cyclin T1; displays 55/125/210/ >227/ >227-fold selectivity for CDK9 versus CDK2/1/4/6/7. |
DC8737 |
SCH900776 S-isomer
|
SCH900776 (S-isomer) is the S-isomer form of SCH900776, which is a potent, selective and orally bioavailable inhibitor of checkpoint kinase Chk1 (IC50 = 3 nM), highly selective against Chk2 (IC50 = 1500 nM) and cyclin-dependent kinase CDK2 (IC50 |
DC7114 |
Dinaciclib (SCH727965)
|
Dinaciclib (SCH727965) is a novel and potent CDK inhibitor for CDK2, CDK5, CDK1 and CDK9 with IC50 of 1 nM, 1 nM, 3 nM and 4 nM, respectively. |
DC10627 |
MSC2530818
|
MSC2530818, a CDK8 inhibitor with the IC50 of 2.6 nM, displays excellent kinase selectivity, biochemical and cellular potency, microsomal stability, and is orally bioavailable. |
DC7493 |
SB1317(TG-02)
|
|
DC28035 |
TCMDC-135051
|
TCMDC-135051 是一种高选择性和有效性的蛋白激酶 PfCLK3 抑制剂,具有低的靶外毒性。TCMDC-135051 可以防止滋养体到裂殖体的转变,破坏转录并减少向蚊子载体的传播。TCMDC-135051 具有抗寄生虫活性 (EC50=320 nM)。 |
DC27001 |
SR-4835
|
SR-4835 是有效,高选择性和 ATP 竞争性的 CDK12/CDK13 双重抑制剂 (CDK12:IC50=99 nM,Kd=98 nM;CDK13:Kd=4.9 nM)。SR-4835 与破坏 DNA 的化学疗法和 PARP 抑制剂协同作用,并引起三阴性乳腺癌 (TNBC) 细胞凋亡。 |
DC9392 |
NVP-LCQ195
|
NVP-LCQ195 (AT9311; LCQ195)是CDK杂环类抑制剂,对CDK1,CDK2,CDK3和CDK5的IC50为1-42 nM。 |
DC9988 |
NSC23005 sodium
|
NSC23005 sodium 是一种新型有效的 p18 抑制剂 (ED50=5.21 nM),在小鼠和人类模型中促进造血干细胞 (HSCs) 扩增。 |